PubRank

Terry Hyslop

Author PubWeight™ 124.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004 28.29
2 Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007 5.40
3 A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 2008 3.02
4 Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol 2011 2.78
5 A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer 2007 2.64
6 Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 2010 2.30
7 MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A 2007 1.90
8 p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A 2009 1.89
9 Tailored navigation in colorectal cancer screening. Med Care 2008 1.79
10 Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med 2004 1.68
11 G protein-coupled receptor kinase 2 expression and activity are associated with blood pressure in black Americans. Hypertension 2009 1.62
12 Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology 2012 1.53
13 Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Cancer Res 2009 1.52
14 A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer. Clin Cancer Res 2006 1.42
15 Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med 2009 1.41
16 Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2005 1.38
17 The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Clin Cancer Res 2005 1.31
18 Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg 2009 1.29
19 A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing. Blood 2011 1.28
20 A uroguanylin-GUCY2C endocrine axis regulates feeding in mice. J Clin Invest 2011 1.27
21 Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003 1.27
22 The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cancer 2004 1.23
23 Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. JAMA 2009 1.21
24 Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med 2003 1.21
25 Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma. Cancer 2011 1.18
26 Racial differences in severe perineal lacerations after vaginal delivery. Am J Obstet Gynecol 2003 1.17
27 Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer 2010 1.16
28 Evaluation of a scaling approach for the bioequivalence of highly variable drugs. AAPS J 2008 1.15
29 GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PLoS One 2012 1.13
30 GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer 2011 1.13
31 Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment. Am J Pathol 2011 1.12
32 Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. Am J Pathol 2010 1.11
33 Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics 2010 1.11
34 Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo. Int J Cancer 2010 1.10
35 Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 2008 1.08
36 Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer. Expert Rev Mol Diagn 2005 1.07
37 Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck 2009 1.07
38 Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. Cancer Res 2010 1.04
39 Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer 2013 1.03
40 Relative quantification based on logistic models for individual polymerase chain reactions. Stat Med 2007 1.02
41 A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy: does the addition of a falciform patch and fibrin glue improve outcomes? J Gastrointest Surg 2012 1.00
42 Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling. Circulation 2011 1.00
43 Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends Biotechnol 2007 0.96
44 Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res 2012 0.96
45 Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis. Cancer Res 2009 0.93
46 Signal transducer and activator of transcription-3 and breast cancer prognosis. Am J Cancer Res 2011 0.91
47 Molecular staging individualizing cancer management. J Surg Oncol 2012 0.90
48 Statistical algorithm for assuring similar efficiency in standards and samples for absolute quantification by real-time reverse transcription polymerase chain reaction. Anal Biochem 2005 0.90
49 Survival associated pathway identification with group Lp penalized global AUC maximization. Algorithms Mol Biol 2010 0.88
50 Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables. Cancer Causes Control 2014 0.87
51 Has the use of routine episiotomy decreased? Examination of episiotomy rates from 1983 to 2000. Obstet Gynecol 2002 0.87
52 Revealing genes associated with vitellogenesis in the liver of the zebrafish (Danio rerio) by transcriptome profiling. BMC Genomics 2009 0.87
53 Factors associated with colorectal cancer screening decision stage. Prev Med 2010 0.86
54 Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma. Radiat Oncol 2010 0.86
55 Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report. Eur J Pharm Sci 2011 0.86
56 A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 2012 0.85
57 Race and response to colon cancer screening interventions. Prev Med 2011 0.85
58 Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab 2015 0.85
59 Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes. Am J Clin Oncol 2015 0.85
60 A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies. Cancer 2011 0.84
61 Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report. AAPS J 2011 0.84
62 Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes. BMC Cancer 2013 0.82
63 Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma. J Gastrointest Surg 2013 0.82
64 A general approach for two-stage analysis of multilevel clustered non-Gaussian data. Biometrics 2006 0.82
65 Genetic variations in stem cell-related genes and colorectal cancer prognosis. J Gastrointest Cancer 2012 0.82
66 Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg 2012 0.81
67 Serum monocyte chemoattractant protein-1 in pancreatic cancer. J Oncol 2011 0.81
68 Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment. Breast Cancer Res 2013 0.80
69 GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients. Expert Rev Mol Diagn 2009 0.80
70 Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy. Med Phys 2009 0.80
71 Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes? Ann Surg 2017 0.79
72 Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests. Int J Cancer 2014 0.79
73 Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells. Future Oncol 2006 0.79
74 Molecular staging estimates occult tumor burden in colorectal cancer. Adv Clin Chem 2010 0.79
75 Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease. Pediatr Blood Cancer 2013 0.78
76 GUCY2C molecular staging personalizes colorectal cancer patient management. Biomark Med 2012 0.78
77 Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma. J Surg Oncol 2011 0.78
78 Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas. Am J Clin Oncol 2003 0.78
79 Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Ann Surg Oncol 2009 0.78
80 Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions. Future Oncol 2012 0.78
81 Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy. Cancer Med 2014 0.77
82 Effectiveness of complete diagnostic examination in clinical practice settings. Cancer Detect Prev 2006 0.77
83 Patients with prior second-trimester loss: prophylactic cerclage or serial transvaginal sonograms? Am J Obstet Gynecol 2002 0.77
84 Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States. J Reprod Med 2006 0.77
85 A multivariate test for population bioequivalence. Stat Med 2007 0.77
86 Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol 2003 0.77
87 The Philadelphia Episiotomy Intervention Study. J Reprod Med 2006 0.77
88 Sample size in pilot genetic studies. Clin Transl Sci 2008 0.75
89 Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces fatty acid synthesis via downregulation of sterol regulatory element binding protein-1 and activation of acetyl CoA carboxylase. J Gastrointest Surg 2013 0.75
90 MicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci 2008 0.75
91 The Effect of Hospital Volume on Breast Cancer Mortality. Ann Surg 2016 0.75
92 Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy. Breast Cancer Res Treat 2014 0.75
93 Journal of Biopharmaceutical Statistics. From the editors. J Biopharm Stat 2009 0.75